MedTrace Logo

Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being

NCT01211912 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2014-09-01

No results posted yet for this study

Summary

This study has two aims:

1. to evaluate placental transfer of acetaminophen from mother to baby transplacentally given from 30 minutes to 24 hours prior to cesarean delivery (34 patients)
2. to understand the impact of maternal acetaminophen use on fetal movement and breathing (20 patients)

Conditions

  • Fetal Testing
  • Transplacental Transfer of Acetaminophen

Interventions

DRUG

Arm 1 (20 patients)

Acetaminophen 1000 mg by mouth once

DRUG

Arm 2 (34 patients)

Acetaminophen 1000 mg by mouth once

Sponsors & Collaborators

Principal Investigators

  • Brian C Brost, MD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01211912 on ClinicalTrials.gov